Novo Nordisk is facing a massive wave of generic competitors to its injectable formulations of GLP-1 agonist semaglutide, used to treat diabetes and obesity, as a key patent in India is due to expire ...
The Rasmussen Reports daily Presidential Tracking Poll for Wednesday shows that 45% of Likely U.S. Voters approve of President Trump’s job performance. Fifty-three (53%) disapprove. The latest figures ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results